nm23 expression in primary cutaneous malignant melanomas

Objective & Hypothesis:Background and Design: We investigated the correlation between nm23 and tumor depth in primary cutaneous malignant melanomas (PCMM).

📊

Key Findings & Data:Materials and Methods: Sixteen cases in sun-exposed areas and 10 cases in nonexposed areas were included into the study.

💡

Conclusion & Impact:Besides the fewer expression of the nm23 in PKMM in sun exposed areas may suggest the more aggressive behavior in those tumors.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Background and Design: We investigated the correlation between nm23 and tumor depth in primary cutaneous malignant melanomas (PCMM). Materials and Methods: Sixteen cases in sun-exposed areas and 10 cases in nonexposed areas were included into the study. Clark Levels (CL) were determined to evaluate tumor depth. Immunohistochemically more than 10% of cytoplasmic staining by nm23 was assessed in a semiguantitative fashion. The extent of staining was estimated as (+), (++), (+++), the intensity of staining was graded as (+), (++), (+++). Results: There were totally 6 PCMM cases with low Clark level (CL I, II, III). The extent of nm23 staining was as follows: in 4 cases (+++), in 1 case (++) and in 1 case (+). The intensity of staining was in 5 cases (+++), in 1 case (++). There were 20 PCMM cases with high CL (CL IV, V). The extent of nm23 staining was as follows; in 15 cases (+++), in 2 cases (++), there was no staining in 3 cases. The intensity of staining was (+++) in 6 cases, (+) in 5 cases, (-) in 3 cases. No significant difference regarding the nm 23 positivity was observed in PCMM in sun exposed areas and nonexposed areas. Conclusion: In all of the cases with low CL there was nm23 staining. This finding suggests tumor suppressor potential of nm23. But the number of cases with high CL that weren't stained by nm23 was fewer on the contrary of the expected. We thought that nm23 expression may not be related to the depth of tumor invasion. Besides the fewer expression of the nm23 in PKMM in sun exposed areas may suggest the more aggressive behavior in those tumors.

Özet

Primer kutanöz malin melanomlarda (PKMM) nm23 ekspresyonu ile tümör derinliği arasında ilişki olup olmadığını araştırmak üzere çalışmaya 16 sı güneş gören 10 u güneş görmeyen alanda saptanan 26 PKMM olgusu incelendi. Tümör derinliği Clark Level (CL) ile belirlendi, immünhistokimyasal olarak nm23 ile tümör hücrelerinde %10 dan fazla sitoplazmik boyanma semikantitatif olarak yaygınlık (+,++,+++) ve yoğunluğuna (+,++,+++) göre değerlendirildi. CL ı düşük olan (CL I, II, III) toplam 6 PKMM olgusunda; nm23 boyanma yaygınlığı 4 olguda (+++), 1 olguda (++), 1 olguda (+) idi, boyanma yoğunluğu ise 5 olguda (+++), 1 olguda (++) idi. CL ı yüksek olan (CL IV, V) toplam 20 PKMM olgusu vardı. nm23 boyanma yaygınlığı 15 olguda (+++), 2 olguda (++) iken, 3 olguda boyanma gözlenmedi. Boyanma yoğunluğu 6 olguda (+++), 6 olguda (++), 5 olguda (+), 3 olguda (-) idi. Güneş gören ve görmeyen alanlardaki PKMM larda nm23 pozitivitesinde anlamlı fark saptanmadı. CL ı düşük olguların tamamında nm23 ile boyanma izlenmesi nm23 ün tümör süpresör etkisini düşündürmektedir ancak CL ı yüksek olguların beklenenin aksine, nispeten daha azında boyanma olmaması nm23 ekspresyonunun tümör invazyon derinliğiyle ilişkili olmayabileceğini akla getirmektedir. Ayrıca güneş gören alanlarda CL ı yüksek PKMM olgularında nm23 ekspresyonunun daha az bulunması, bu alanlarda görülen PKMM lann daha agresif olabileceğini düşündürmüştür.

🔖

Cite This Article

SEÇKİN, S., PKAER, İ., ÖZSOY, Ş. (2022). nm23 expression in primary cutaneous malignant melanomas. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 39 - Sayı: 3, 178–181. https://ajindex.com/articles/622191

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (9)

Hartsough MT, Steeg PS: nm23/nucleoside diphosphate kinase in human cancers. J Bioenerg Biomembr 2000;30(3):301-308
Lombardi D, Lacombe ML, Paggi MG: nm23: unraveling its biological function in cell differentiation. J Cell Physiol 2000;182(2):144-149
Hamby CV, Abbi R, Prasad N, et al. Expression of a catalytically inactive H118Y mutant of nm23-H2 supresses the metastatic potential of line IV CL 1 human melanoma cells. Int J Cancer 2000;88:547-553 4. Backer JM, Mendola CB, Kovesd I, et al. Chromozomal localizationand nücleoside diphosphate kinase activity of human metastasis supressor genes nm23-1 and nm23-2. Oncogene 1993;8:497-502 5. Leone A, Flataw U, King CR, et al. Reduced tumor incidence metastatic potential and cytokine responsivines of nm23 transfected melanoma cells. Cell1991;651:25-35 6. Hart JR, Easty D. Identification of genes controlling metastatic behaviour. BJ Cancer 1991; 63:9-12
Reichrath J, Seyfried P, Brawn R, et al. Expression of nm23 protein in acquired melanocytic nevi malignant melanoma and metastases of malignant melanoma an immünohistochemical assesment in human skin. Dermatology1997; 194: 136-139
McDermott NC, Milburn C, Curran B, Kay EW, Barry Walsh C, Leader MB: Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome. J Pathol 2000;190(2):157-162
Holmes SC, MacKie RM: The value of nm23 expression as an independent prognostic indicator in primary thick melanoma. J Cutan Pathol 1996;23(4):344-349
Clark WH, Elder DB, Giveny D, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 81: 1893-1904
Mangini Li N, Bhawan J. New prognostic factors of cutaneous melanoma: areview of the literature. J Cutan Pathol 2002;29:324-340
Demunter A, Stas M, Degreef H, De Wolf-Peeters C, van den Oord JJ: Analysis of n- and k-ras mutations in the distinctive tumor progression phases of melanoma. J Invest Dermatol 2001;117(6):1483-1489.